Paris, November 27, 2024 – Capgemini announced the large success of its eleventh Employee Share Ownership Plan (ESOP). For Aiman Ezzat, Chief Executive Officer of the Capgemini Group: “With more than ...

Recognising WNS-Vuram, Deloitte, Cognizant, KPMG, Accenture, and Via Appia for delivering process excellence ...

CALGARY, Alberta, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today provided an update of a modularized cryogenic natural gas processing ...

GREENWOOD VILLAGE, Colo., Nov. 27, 2024 (GLOBE NEWSWIRE) -- FrankSpeech Broadcast Network is making waves in the world of independent media, delivering its strongest quarter ever in Q3 2024. The ...

Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), today announced that on November 25, 2024, it received a delinquency notification letter from the Nasdaq Stock Market LLC ("Nasdaq") ...

NAH will complete, test and evaluate the 10-1 Well in the coming weeks to confirm the presence of helium and assess commerciality of the potential helium discovery. The 10-1 Well is part of the ...

Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on November 25, 2024, which indicated that the Company was not in compliance ...

The Company has also scheduled a conference call for Friday, December 13, 2024, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s ...

Fundamental Global Inc. (Nasdaq: FGF) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc., today announced that it has declared a quarterly cash dividend on its 8.00% ...

The webcasts will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/news-and-events/events. Webcasts will also be archived for a minimum of thirty days.

Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) being developed for the treatment of multiple rare diseases including Classic Galactosemia, Sorbitol ...

Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today ...